BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zidovudine

Below is an extended Zidovudine research listing. Click here to return to the Zidovudine main in depth entry.

Recent Publications on Zidovudine:

Associations of Chemokine Receptor Polymorphisms With HIV-1 Mother-to-Child Transmission in Sub-Saharan Africa: Possible Modulation of Genetic Effects by Antiretrovirals.
BACKGROUND:: HIV-1 mother-to-child transmission (MTCT) remains an...
Direct Link
11th October, 2008
From the *Department of Pediatrics, University of California San Diego, La
Impact of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Drug Resistance Mutation Interactions on Phenotypic Susceptibility.
Abstract The role specific reverse transcriptase (RT) drug resistance...
Direct Link
11th October, 2008
Department of Internal Medicine, Division of Infectious Diseases, The
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
OBJECTIVES: To determine whether mutations conferring drug resistance are...
Direct Link
9th October, 2008
Department of Genitourinary Medicine, Guy's and St Thomas' NHS Foundation
Zidovudine monotherapy in pregnancy: is it state of the art?
OBJECTIVES: To determine whether mutations conferring drug resistance are...
Direct Link
9th October, 2008
Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. 9th October, 2008
Department of Medicine, University of Washington, Seattle, WA, USA.
Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools. 9th October, 2008
Department of Preclinical Drug Metabolism, Gilead Sciences, Inc., Foster
Pathogenesis and treatment of lipodystrophy: what clinicians need to know. 8th October, 2008
Keck School of Medicine of the University of Southern California, Los
Development of an Optimized Dose for Co-formulation of Zidovudine with Drugs that Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model.
In vitro selection studies and data from large genotype databases from...
Direct Link
8th October, 2008
Center for AIDS Research, Laboratory of Biochemical Pharmacology,
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
This cohort study was conducted amongst female patients manifesting...
Direct Link
7th October, 2008
Medecins Sans Frontieres, 7089 Kigali, Rwanda.
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
CONTEXT: Long-term studies of tolerance to perinatal exposure to...
Direct Link
4th October, 2008
Inserm, U822, Le Kremlin-Bicetre, France.
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
BACKGROUND: Cases of renal dysfunction in patients receiving tenofovir...
Direct Link
4th October, 2008
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Prediction of drug clearance by glucuronidation from in vitro data: Use of combined P450 and UGT cofactors in alamethicin activated human liver microsomes.
Glucuronidation via UDP-glucuronosyltransferase (UGT) is an increasingly...
Direct Link
4th October, 2008
University of Manchester.
Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice.
Zidovudine (3'-azido-3-deoxythymidine; AZT) is the main antiretroviral...
Direct Link
1st October, 2008
Center for Functional Genomics, Division of Systems Toxicology, National
Inhibition of cation channels and suicidal death of human erythrocytes by zidovudine.
Zidovudine, a drug widely used in the treatment of AIDS, has been shown to...
Direct Link
30th September, 2008
Department of Physiology, University of Tubingen, Germany; Department of
[Anti-HIV activities of Achyranthes bidentata polysaccharide sulfate in vitro and in vivo] 30th September, 2008
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional